Indefinite Delivery Contract SPM2DP07D0004
- Not listed
- The federal contract IDV is an Indefinite Delivery Contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian agency, to Novartis Vaccines And Diagnostics, Inc. on April 24, 2009. The contract has a ceiling value of $6,709,043.08 and a period of performance through February 28, 2010. The contract is for the procurement of products and services related to the FLU 2009 Vaccine Formulation and Administration (VFA) program. Although no...
- The Department of Veterans Affairs National Acquisition Center awarded a single award IDV to Seqirus USA Inc. on March 15, 2021 with a potential value of $67,604,685.53. Task orders issued against the IDV by the VA, Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Healthcare Center procure influenza virus vaccines for the 2021-2022 season. Vaccines provided under the IDV and related task orders include those in multi-dose vials and single dose syringes for adults and...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...
- The federal contract IDV award was issued by a U.S. federal government agency to Novartis Vaccines And Diagnostics, Inc., a foreign-owned, for-profit organization. The contract type is an Indefinite Delivery Contract with a potential value of $3,378,319.52. The contract's description is "BIOMEDICAL (BASIC)," indicating it is for basic biomedical products and services. Under this IDV, a single task order was issued with a potential value of $76,625,000.00. This task order, also for...
- The federal contract IDV award SPE2DP18D0006 is a single-award indefinite delivery contract issued by the U.S. Department of Defense (DoD) Medical Supply Chain to the pharmaceutical company Glaxosmithkline, LLC. The contract, valued at a ceiling of $27,848,725.95, enables the DoD to order influenza virus vaccines and other pharmaceutical products from Glaxosmithkline, a foreign-owned for-profit organization, over the term of the agreement. Task orders issued under the IDV provide for the firm...
- The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
- The federal contract IDV award SPE2DP24D0005 is a single award indefinite delivery contract with a ceiling value of $2,327,325.00, awarded by the Defense Logistics Agency's Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of influenza virus vaccines, with a period of performance through March 12, 2025. A task order with award ID SPE2DP24D0005|SPE2DP24F3249 was issued on March 14, 2024 for a firm fixed price...
- The IDV award provides Sanofi Pasteur Inc. with an IDIQ contract vehicle to supply influenza virus vaccines and related services to federal agencies through 2024. Task orders issued to date involve delivery of vaccines by the prime contractor to locations of the Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, and other government customers. Performance spans multiple years at places including Swiftwater, PA, with total task order obligations approaching $80 million. The...
- The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Glaxosmithkline Holdings (Americas) Inc. The contract, identified as HHSD200200930521I, has a ceiling value of $809,252,070.00 and a period of performance from July 1, 2009 to June 30, 2010. The contract, known as VFA 2009, does not have any set-asides and was awarded as a multiple-award vehicle....
- SPM2DP07D0004Indefinite Delivery Contract
- 601Federal Contract Awards
This federal contract IDV award was issued by the Defense agency Medical Supply Chain to the prime contractor Medimmune, LLC for the procurement of influenza virus vaccines. The contract was a single-award, indefinite delivery contract with a total ceiling value of $23,900,000. The contract included numerous firm-fixed price task orders for the delivery of influenza vaccines to the Shepherdsville, KY area, with individual task order values ranging from a few thousand to over $100,000. The contract had an overall period of performance from July 2007 to July 2008. Based on the task order details, it appears this IDV contract was focused on supporting the government's influenza vaccination efforts, likely for military or other defense-related personnel. No set-asides were used for this procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 7/19/07 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPM2DP07D0004-0414 | Medimmune, LLC | $44.1k | 10/18/07 | 10/18/07 | 10/18/07 | |
Delivery Order SPM2DP07D0004-0536 | Medimmune, LLC | $22.8k | 10/29/07 | 10/30/07 | 10/29/07 | |
Delivery Order SPM2DP07D0004-0688 | Medimmune, LLC | $14.3k | 11/5/07 | 11/5/07 | 11/5/07 | |
Delivery Order SPM2DP07D0004-0260 | Medimmune, LLC | $6.1k | 8/21/07 | 10/4/07 | 8/21/07 | |
Delivery Order SPM2DP07D0004-0338 | Medimmune, LLC | $3.7k | 10/12/07 | 10/12/07 | 10/12/07 |